NEW YORK, Oct. 16 – Hybrigenics of Paris and the Institut Pasteur have expanded their collaborative efforts with an agreement to work together exclusively on a project designed to link functional proteomics and infectious diseases.

Under the terms of the deal, Hybrigenics and the Institut Pasteur, which have been working together since 1998, will validate therapeutic targets that can be used in the treatment of infectious diseases. Hybrigenics will have the exclusive right to any results generated by the collaboration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.